Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole Augmentation in MDD
NCT01429831Phase 4Completed
- Sponsor
- Otsuka Holdings
- Start
- Sep 2011
- Primary completion
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of aripiprazole in major depressive disorder (MDD), sponsored by Otsuka Holdings. Started Sep 2011; status: completed.
02
Drugs
aripiprazole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01429831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01429831.